Medicamen Biotech Limited (NSE:MEDICAMEQ)

Medicamen Biotech Revenue

In the fiscal year ending March 31, 2026, Medicamen Biotech had annual revenue of 2.01B INR with 19.90% growth. Medicamen Biotech had revenue of 623.82M in the quarter ending March 31, 2026, with 80.23% growth.

• Revenue: 2.01B
• Revenue Growth: +19.90%
• P/S Ratio: 1.55
• Revenue / Employee: 5.34M
• Employees: 376
• Market Cap: 3.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.01B	333.36M	19.90%
Mar 31, 2025	1.68B	-117.59M	-6.56%
Mar 31, 2024	1.79B	384.39M	27.29%
Mar 31, 2023	1.41B	254.22M	22.02%
Mar 31, 2022	1.15B	27.29M	2.42%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error